A Clinical Study of Gadoteric Acid in Non-Coronary Magnetic Resonance (MR) Angiography
Phase 4
Completed
- Conditions
- Arterial Occlusive Disease
- Registration Number
- NCT00447889
- Lead Sponsor
- Guerbet
- Brief Summary
This is a clinical study of gadoteric acid in non-coronary MR angiography.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Male or female, at least the age of legal maturity
- Strongly suspected of having non-coronary arterial disease, detected clinically
- Scheduled to undergo x-ray angiography examination
- Female patients must be using effective contraception or be surgically sterilized or post-menopausal.
- Females of childbearing potential must have a documented negative urine pregnancy test.
Exclusion Criteria
- Contraindication to magnetic resonance imaging (MRI)
- Any metallic medical device in the vascular territory for which the patient is to undergo imaging examinations
- Congenital morphologic vascular abnormalities
- Known allergy to gadolinium chelates
- Pregnant, breast feeding, or planning to become pregnant during the trial
- Received a gadolinium complex within 2 days or iron oxide nanoparticles within 7 days before the gadoteric acid-enhanced magnetic resonance angiography (MRA) examination.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Asan Medical Center
🇰🇷Seoul, Korea, Republic of